News & Updates

Treatment with proton therapy reirradiation for head and neck cancer appears to improve survival outcomes in patients, but this benefit comes with substantial toxic effects, according to a study.

Treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors appears to have the added benefit of reducing the incidence of obstructive airway disease (OAD) in Asian patients with type 2 diabetes (T2D), as shown in a study from Hong Kong.

One-time ex-vivo gene therapy with betibeglogene autotemcel (beti-cel) reduces the need for transfusion in patients with transfusion-dependent beta-thalassaemia in an analysis of studies presented at ASH 2022.

Childhood cancer survivors (CCS) appear to have an increased risk of low bone mineral density (BMD) and fracture compared with the general population, according to a cross-sectional study from the Netherlands.

The use of immune checkpoint inhibitors (ICIs) for the treatment of various cancers appears to have hepatotoxic effects, the risk of which is greater with ICI combination therapy than with monotherapy, as reported in a recent study.

Use of lidocaine 4% cream reduces total cry duration after vaccinations of infants relative to placebo, as shown in a study, noting that both caregivers and nurses are willing to use this cream for pain management in a clinic setting if available.

Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in combination with multiple daily insulin injections (MDII) is associated with an improvement in A1c and a reduction in insulin doses without increased hypoglycaemia, reports a study.